Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
2.700
0.00 (0.00%)
At close: Feb 4, 2026
Helix BioMedix Company Description
Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States.
It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies.
The company was founded in 1988 and is based in Bothell, Washington.
Helix BioMedix, Inc.
| Country | United States |
| Founded | 1988 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Robin Carmichael |
Contact Details
Address: 19125 Northcreek Parkway Bothell, Washington 98011 United States | |
| Phone | 425 402 8400 |
| Website | helixbiomedix.com |
Stock Details
| Ticker Symbol | HXBM |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US4232875074 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Robin L. Carmichael | President, Chief Executive Officer and Chairman |